Comparative efficacy of progesterone and vitamin D in improving functional outcomes after traumatic brain injury
Ukrainian Neurosurgical Journal · 29.03.2026 · 32 (1) · 92-98
DOI: 10.25305/unj.337777 ↗Kurz gefasst
Fachartikel in der Zeitschrift Ukrainian Neurosurgical Journal, online erschienen am 29.03.2026. Verfasst von Kenzie Ongko Wijaya und 3 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Traumatic brain injury (TBI) remains a major clinical challenge in neurosurgery due to its heterogeneous pathophysiology and the limited availability of effective pharmacological interventions. Progesterone and vitamin D have demonstrated neuroprotective and anti-inflammatory properties in preclinical models; however, their translational efficacy in clinical trials remains inconclusive. Clarifying their therapeutic roles may help inform adjunctive strategies in the acute management of neurotrauma.
Objectives
To assess the neuroprotective effects of progesterone and vitamin D in enhancing functional recovery following moderate to severe TBI, and to compare the clinical efficacy of these agents based on standardized neurological outcome measures derived from randomized controlled trials (RCTs).
Methods
A systematic review and meta-analysis were conducted in accordance with the PRISMA guidelines. Randomized controlled trials (RCTs) were identified through searches of PubMed, EMBASE, Web of Science, and the Cochrane Library, comparing progesterone and/or vitamin D with placebo in patients with traumatic brain injury (TBI). Studies reporting Glasgow Outcome Scale–Extended (GOS-E) outcomes were included. Standardized mean differences (SMDs) with 95% confidence intervals (CIs) were calculated using Review Manager version 5.4. Study quality and heterogeneity were assessed.
Results
Six RCTs were included: three progesterone trials (n = 1,426) and three vitamin D trials (n = 192). Progesterone showed no significant improvement in functional outcomes compared with placebo (SMD = −0.07; 95% CI: −0.32 to 0.19; p = 0.60; I² = 58%). Vitamin D demonstrated a non-significant trend toward improved outcomes (SMD = 0.37; 95% CI: −0.27 to 1.02; p = 0.26; I² = 78%). Variability in trial design, timing of intervention, and baseline vitamin D deficiency status may have influenced the observed effects.
Conclusions
Although neither agent showed standalone efficacy, their safety and complementary mechanisms suggest promise for combinatorial or biomarker-guided approaches. This meta-analysis highlights the need for early, precision-targeted, and stratified neuroprotective trials in TBI care.
Zitieren
APA
Wijaya, K. O., Utomo, N. P., Wibisono, M. A., & Sadjiman, E. B. (2026). Comparative efficacy of progesterone and vitamin D in improving functional outcomes after traumatic brain injury. Ukrainian Neurosurgical Journal, 32(1), 92-98. https://doi.org/10.25305/unj.337777
Vancouver
Wijaya KO, Utomo NP, Wibisono MA, Sadjiman EB. Comparative efficacy of progesterone and vitamin D in improving functional outcomes after traumatic brain injury. Ukrainian Neurosurgical Journal. 2026;32(1):92-98. doi:10.25305/unj.337777
BibTeX
@article{Wijaya2026,
author = {Wijaya, Kenzie Ongko and Utomo, Nunki Puspita and Wibisono, Muhammad Andika and Sadjiman, Endro Basuki},
title = {Comparative efficacy of progesterone and vitamin D in improving functional outcomes after traumatic brain injury},
journal = {Ukrainian Neurosurgical Journal},
year = {2026},
volume = {32},
number = {1},
pages = {92--98},
doi = {10.25305/unj.337777}
}
EUVIMED